Hillhouse Investment Management, Ltd.
10% Owner

Hillhouse Investment Management, Ltd. insider trades: ArriVent BioPharma (AVBP) stock buys and sales

10% Owner, ArriVent BioPharma Last trade Dec 10, 2025 9 Form 4 filings
$13.0M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2017
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hillhouse Investment Management, Ltd. reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 10, 2025AVBP↓ Sell$13.0M
Dec 2, 2024BGNE↓ Sell$3.57B
Jan 30, 2024AVBP↑ Buy$10.0M
Jun 14, 2023BGNE↓ Sell$226.3M
Jun 12, 2023BGNE↓ Sell$597.2M
Oct 25, 2021ENFN↓ Sell$10.3M
Nov 13, 2017APLS↑ Buy$20.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVBP insiders

Open-market trades in the last 12 months

About Hillhouse Investment Management, Ltd.'s insider trades

Hillhouse Investment Management, Ltd. is a 10% owner of ArriVent BioPharma (AVBP). Since Nov 13, 2017, it has reported 2 open-market purchases worth $30.0M and 5 sales worth $4.42B on SEC Form 4. In the last 12 months: 1 sale ($13.0M).

Its filings also include conversions (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.